Abstract:The collagen proteins are the principal component of the extracellular matrix and are the most abundant protein family in humans. Therefore, collagens form the major protein component of bone, tendon and cartilage. During collagen biosynthesis, proline and lysine residues are enzymatically converted to ( 2S,4R )-hydroxyproline, ( 2S,3S )-hydroxyproline and ( 2S,5R )-hydroxylysine by the collagen prolyl-4-hydroxylases (C-P4Hs), prolyl-3-hydroxylases (P3Hs) and procollagen-lysine, 2-oxoglutarate 5-dioxygenases (PLODs) respectively. The C-P4Hs, P3Hs and PLODs are members of the Fe II and 2-oxoglutarate dependent oxygenase (2OG oxygenase) superfamily. Despite being amongst the first 2OG oxygenases to be identified, the collagen hydroxylases are poorly understood from structural and biochemical perspectives, a consequence of inefficient recombinant production methods. Initial efforts focussed on developing a robust expression system for recombinant C-P4H. An E. coli expression system was pursued to allow for relatively large quantities of protein to be produced, as required for structural studies. A number of novel expression constructs were generated and used in small-scale expression trials. However, attempts to isolate purified C-P4H tetramer have ultimately proved unsuccessful. A prolyl hydroxylase from Paramecium bursaria Chlorella Virus I (vCPH), was pursued as a model collagen prolyl hydroxylase; production of vCPH in E. coli affords large quantities of high purity recombinant protein for subsequent analyses. vCPH catalyses the formation of (2S,4R)-hydroxyproline at proline 3 and proline 5 of the short 8-mer peptide PAPKPAPK and kinetic analyses have revealed that the ascorbate dependence of vCPH-catalysis at these two positions differs significantly, indicating that ascorbate dependence of the collagen prolyl hydroxylases varies dependent upon the residues adjacent to the target residue. A vCPH inhibition assay was developed and a library of potential inhibitors was screened. This screen included compounds that inhibit a different subfamily of 2OG dependent prolyl-4-hydroxylases, the hypoxia inducible factor prolyl hydroxylases (HIF PHDs), which also catalyse the formation of ( 2S,4R )-hydroxyproline. The studies revealed that inhibitors of the HIF PHDs that are currently in clinical trials also inhibit vCPH. However, analysis of novel HIF PHD inhibitors and inhibitors of the prolyl-3-hydroxylase OGFOD1 indicate that achieving selectivity between these prolyl hydroxylases is possible. The inhibition studies have been complemented with amino acid analyses of collagen samples. No evidence for the existence of hydroxylated residues other than ( 2S,4R )-hydroxyproline, ( 2S,3S )-hydroxyproline and ( 2S,5R )-hydroxylysine was acquired. These amino acid analysis approaches may be taken further to analyse collagen samples derived from tissue to assess hydroxylation levels in diseased tendon. Additionally, metathesis-derived lysine analogues have been synthesised and used to analyse 2OG-dependent histone demethylase (KDM) catalysis. These analogues have revealed new modes of activity with KDM3A and provided insight into the charge and conformational requirements of 2OG-dependent KDM catalysis. Overall, the work presented in this thesis has provided insight into the biochemistry of a collagen prolyl hydroxylase and demonstrated the potential for the development of selective inhibitors of prolyl hydroxylases. Additionally, novel reactions catalysed by histone demethylases have been observed.

Characterization of recombinant human prolyl 3-hydroxylase isoenzyme 2, an enzyme modifying the basement membrane collagen IV

Collagen prolyl 4-hydroxylase isoenzymes I and II have sequence specificity towards different X-Pro-Gly triplets

Biological role of prolyl 3-hydroxylation in type IV collagen

Re-evaluation of lysyl hydroxylation in the collagen triple helix: lysyl hydroxylase 1 and prolyl 3-hydroxylase 3 have site-differential and collagen type-dependent roles in lysine hydroxylation

Conformational preferences of substrates for human prolyl 4-hydroxylase

Studies on collagen post-translational modifications

New Strategy for Expression of Recombinant Human Prolyl-4-Hydroxylase in <i>Pichia pastoris</i>

High-level production of human collagen prolyl 4-hydroxylase in Escherichia coli

Structural enzymology binding studies of the peptide-substrate-binding domain of human collagen prolyl 4-hydroxylase (type-II): High affinity peptides have a PxGP sequence motif

The active site of an algal prolyl 4-hydroxylase has a large structural plasticity

Characterization of a novel Caenorhabditis elegans prolyl 4-hydroxylase with a unique substrate specificity and restricted expression in the pharynx and excretory duct

Tissue-specific collagen hydroxylation at GEP/GDP triplets mediated by P4HA2

Prolyl 4-hydroxylases, key enzymes in the synthesis of collagens and regulation of the response to hypoxia, and their roles as treatment targets

Bacillus anthracis Prolyl 4-Hydroxylase Modifies Collagen-like Substrates in Asymmetric Patterns

Prolyl 4-Hydroxylase: Substrate Isosteres in Which an (E)- or (Z)-Alkene Replaces the Prolyl Peptide Bond

Co-expression of recombinant human prolyl with human collagen α1 (III) chains in two yeast systems

Human Collagen Prolyl 4-Hydroxylase Is Activated by Ligands for Its Iron Center

Severe Extracellular Matrix Abnormalities and Chondrodysplasia in Mice Lacking Collagen Prolyl 4-Hydroxylase Isoenzyme II in Combination with a Reduced Amount of Isoenzyme I

Characterization of PPIB Interaction in the P3H1 Ternary Complex and Implications for Its Pathological Mutations.

Hypoxia-inducible factor-1 (HIF-1) but not HIF-2 is essential for hypoxic induction of collagen prolyl 4-hydroxylases in primary newborn mouse epiphyseal growth plate chondrocytes

The crystal structure of an algal prolyl 4-hydroxylase complexed with a proline-rich peptide reveals a novel buried tripeptide binding motif